MLTX Stock Price
MoonLake Immunotherapeutics
$10.82
+$0.24(+2.27%)
31
Overall
60
Value
9
Tech
26
Quality
Market Cap
$900.43M
Volume
2.01M
52W Range
$8.18 - $23.29
Target Price
$33.46
MLTX stock price is $10.82 (+2.27% on the day), giving MoonLake Immunotherapeutics a market cap of $900.43M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MLTX Stock Overview
- Price
- $10.82
- Previous close
- $10.58
- Open
- $10.58
- Market cap
- $900.43M
- P/E ratio
- -4.0
- 52-week range
- $8.18 - $23.29
- 1-year price target
- $33.46
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 31
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical stage biopharmaceutical company, engages in developing therapies. The company develops Sonelokimab, a novel tri-specific investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLTX | $10.82 | +2.3% | 2.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MoonLake Immunotherapeutics Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW